Brief: Cosette Pharmaceuticals Expands Branded Portfolio Through Acquisition Of Sympazan® And Additional Products From Assertio
08/04/2026 22:10
April 8 (Reuters) - Assertio Holdings Inc ASRT.O: COSETTE PHARMACEUTICALS EXPANDS BRANDED PORTFOLIO THROUGH ACQUISITION OF SYMPAZAN® AND ADDITIONAL PRODUCTS FROM ASSERTIO Source text: ID:nBw9cVmfpa Further company coverage: ASRT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Assertio Holdings
See all newsBrief: Assertio Announces Completion Of Merger With Zydus Lifesciences And Fundamental Change
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. STOCKS ON THE MOVE -Fervo, Sensata Technologies, Akamai
U.S. STOCKS ON THE MOVE-Chipmakers, Dynatrace, Alibaba